Drugs / Cunermuspir
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04737278 | Jan → May 2014 | neuralgia | Mitosynergy LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cunermuspir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04737278 ↗ |
| Known as | Niacin-cuprous chelate | ChEMBL registry synonym — accepted as the source's own label CHEMBL6068509 ↗ |
| Modality | Small molecule | — CHEMBL6068509 ↗ |